|
New York Medical College: It Takes Trial and Error to Reach Discovery
Clinical trials are less about certainty than discovery—sometimes substantiating a hypothesis, sometimes proving it wrong, and at times landing somewhere in between. Such was the case with the results of a recent clinical trial published in The Lancet by an international group of investigators, including Stephan Mayer, M.D., professor of neurosurgery and of neurology at New York Medical College, that examined the use of recombinant factor VIIa, which stimulates blood coagulation, to treat intracerebral hemorrhage (ICH). Despite advances, ICH remains the most devastating type of stroke, with nearly half of patients dying within 30 days and only 20 percent functionally independent after six months. Learn more |